atyrpharma.com - ATYR Net Assets per Single Share

Graphic logo of aTyr Pharma, Inc. (ATYR)

aTyr Pharma, Inc. (ATYR) is recognized as an innovator in tRNA synthetase immunology and enjoys high trust among physicians. A review of the book value per share on GURU.Markets reveals that the current figure is 0.49. The business fundamentals are based on the success of efzofitimod in treating sarcoidosis, while operational flexibility is maintained by outsourcing manufacturing and trials to third-party contractors.

aTyr Pharma Inc (ATYR): Share Book Value from 06/06/2024 to 10/27/2026

atyrpharma.com - analytical breakdowns and key metrics (ATYR)

- price and consensus price forecast:
Stock Quotes aTyr|ATYR - Average Forecast Price
- market capitalization data:
Market Value aTyr Pharma, Inc.|ATYR - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share aTyr Pharma|ATYR - Net Asset Value|Market Capitalization to Book Value Ratio atyrpharma.com|ATYR - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital aTyr Pharma, Inc.|ATYR - Long-Term Debt to Capital|Short-Term Debt to Equity aTyr Pharma|ATYR - Aggregate Debt Obligations|Debt to Book Capitalization Ratio aTyr Pharma, Inc.
Fundamental company valuation:aTyr - ATYR
Manufactured products of aTyr Pharma

Book value per share determines the portion of net assets attributable to a single security, allowing for an assessment of the issuer's actual tangible asset base regardless of market fluctuations. The trend in book value per share reflects the capitalization of intellectual property held by aTyr Pharma (ATYR) within the lung immunotherapy sector, confirming the company's fundamental stability on its path toward drug commercialization.

Competitors of aTyr Pharma, Inc. (ATYR)

ARGX (Argenx) - Accounting Value per Share|BNTX: Net Asset Value per Share|Net Assets per Single Share Abivax Corp ABVX|ADMA (admabiologics.com) - Accounting Value of a Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Astria Pharma - Book Value per Share|enGene Corp (ENGN) - Book Value per Share|RAPT - Accounting Value per Share|Book Price of a Share Aerovate Therapeutics|Accounting Value per Share ACRS (Aclaris Therapeutics, Inc.)|Net Asset Value per Share KYTX|Tiziana Life Sciences PLC (TLSA) - Net Assets per Single Share|Accounting Value of a Share Cabaletta Bio Inc CABA|Accounting Value per Share Ventyx Biosciences|theratech.com - Accounting Value of a Share|Net Assets per Single Share Avalo Therapeutics|ELDN - Share Book Value|Book Value per Share Agenus Inc AGEN|Climb Bio, Inc (CLYM) - Accounting Value of a Share|ZURA (Zura Bio Limited) - Book Value per Share|Book Value per Share ADAG|ImageneBio Inc (IMA) - Net Assets per Single Share|Accounting Value of a Share STTK (shattucklabs.com)|Equillium - Net Assets per Single Share|Accounting Value per Share Connect Biopharma Holdings CNTB|Immunic Inc - Book Value per Share|Atara Biotherapeutics (ATRA) - Book Value per Share|Accounting Value per Share inflarx.de IFRX|X4 Pharmaceuticals Inc. (XFOR) - Accounting Value of a Share|ACET: Book Value per Share|Net Assets per Share CELU|Net Assets per Single Share INmune Bio, Inc. INMB|Equity per Share barinthusbio.com (BRNS)|Kezar Life Sciences, Inc. - Book Value per Share|SABS - Accounting Value per Share|Accounting Value per Share AKTX (Akari Therapeutics plc)|ENLV - Net Assets per Share|QTTB: Book Value per Share|Book Value per Share geovax.com|Edesa Biotech (EDSA) - Accounting Value per Share|Book Price of a Share iBio Inc (IBIO)|Carisma Therapeutics - Accounting Value per Share|Net Asset Value per Share XTLB (XTL Bio)|Net Assets per Single Share Bolt Biotherapeutics, Inc.|HCW Biologics, Inc. - Accounting Value of a Share|Net Assets per Single Share Aptevo|AIM - Share Book Value|Book Value per Share aditxt.com ADTX|GRI Bio Corporation (GRI) - Accounting Value of a Share|XRTX (XORTX Therapeutics Inc.) - Book Value per Share|Book Value per Share HIND|Revelation Biosciences, Inc. (REVB) - Net Assets per Single Share|Accounting Value of a Share INDP (Indaptus Therapeutics Inc)|Scinai - Net Assets per Single Share|Accounting Value per Share CalciMedica Inc CALI|Affimed Therapeutics - Book Value per Share|Allakos Inc. (ALLK) - Book Value per Share|Accounting Value per Share hookipapharma.com HOOK|IGM Biosciences (IGMS) - Accounting Value of a Share|ITOS: Book Value per Share|Net Assets per Share OCEA|Net Assets per Single Share TCBP (TC Biopharm)|Accounting Value per Share THRD (thirdharmonicbio.com)